课题基金 / 基金详情

Airway Epithelial NF-kB Activation by CpG DNA

Airway Epithelial NF-kB Activation by CpG DNA
CpG DNA 激活气道上皮 NF-kB
批准号:
6801113
负责人:
Matthew E Poynter
金额:
$10.8万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-15 至 2006-06-30

项目摘要

项目成果

Matthew E Poynter的其他基金

相似基金

相关文献

中文摘要
翻译
细支气管上皮细胞是重要的第一道防线, 吸入的环境刺激物,包括微生物产物,如含CpG的 未甲基化的DNA本提案中要检验的假设是 CpG DNA是否诱导信号转导,最终激活 转录因子NF-κ B。提出了模式识别 Toll样受体(TLR)9由细支气管表达。 上皮细胞并启动由CpG DNA诱导的信号传导。将 检测了NF-κ B调节的多聚体的表达和活性, 免疫球蛋白受体(pIR),对伊加和IgM的转运至关重要, 支气管上皮细胞的基底面至顶面, CpG DNA最后,这些通路在细支气管中的调节 可以在治疗上利用CpG DNA对上皮细胞的作用, 通过增加分泌免疫球蛋白水平来保护。的 假设将被测试如下:具体目标1)证明, 非甲基化的免疫刺激性含CpG的DNA序列(CpG DNA)诱导 细支气管上皮细胞激活NF-κ B的信号传导事件 细胞具体目标2)证明涉及NF-κ B的信号传导事件 激活调节多聚免疫球蛋白的诱导型表达 在暴露于CpG DNA的细支气管上皮细胞中的plgr受体。具体 目的3)证明Toll样受体9(TLR 9)介导Toll样受体9的活化。 CpG DNA检测细支气管上皮细胞NF-κ B和pIgR mRNA表达 具体目的4)证明鼻内CpG DNA施用增加了 通过TLR 9介导的NF-kB在气道中分泌免疫球蛋白水平 由细支气管上皮细胞激活。
英文摘要
The bronchiolar epithelium is an important first line of defense against inhaled environmental stimuli, including microbial products such as CpGcontaining unmethylated DNA. The hypothesis to be tested in this proposal is whether CpG DNA induces signal transduction culminating in activation of the transcription factor NF-kappaB. It is proposed that the pattern recognition receptor (PRR) Toll Like Receptor (TLR)9 is expressed by bronchiolar epithelial cells and initiates signaling induced by CpG DNA. It will be examined whether expression and activity of the NF-kappaB-regulated polymeric immunoglobulin receptor (pIR), essential for the transport of IgA and IgM from the basal to the apical surface of bronchiolar epithelial cells, is augmented by CpG DNA. Finally, the modulation of these pathways in bronchiolar epithelium by CpG DNA may be therapeutically exploited to afford mucosal protection through the augmentation of secretary immunoglobulin levels. The hypothesis will be tested as follows: Specific aim 1) Demonstrate that unmethylated immunostimulatory CpG-containing DNA sequences (CpG DNA) induce signaling events culminating in NF-kappaB activation by bronchiolar epithelial cells. Specific aim 2) Demonstrate that signaling events involving NF-kappaB activation modulate the inducible expression of the polymeric immunoglobulin receptor (plgr) in bronchiolar epithelial cells exposed to CpG DNA. Specific aim 3) Demonstrate that Toll Like Receptor 9 (TLR9) mediates the activation of NF-kappaB and mRNA expression of pIgR in bronchiolar epithelial cells by CpG DNA. Specific aim 4) Demonstrate that intranasal CpG DNA administration augments secretary immunoglobulin levels in the airway through TLR9-mediated NF-kB activation by bronchiolar epithelial cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ketone Body Supplementation in Obese Asthma
Serum Amyloid A3 in Allergic Asthma: An Endogenous Mediator of Disease Severity
Serum Amyloid A3 in Allergic Asthma: An Endogenous Mediator of Disease Severity
Serum Amyloid A3 in Allergic Asthma: An Endogenous Mediator of Disease Severity
国内基金
海外基金
自供能传感阵列同步量化游离DNA与PSA实现前列腺癌的诊断和预后判断
  • 批准号:
    JCZRLH202601177
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
二氢杨梅素通过线粒体代谢重编程抑制DNA同源重组修复逆转口腔癌细胞放疗抵抗的机制研究
  • 批准号:
    2026JJ80500
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    阳帆
  • 依托单位:
乳酸通过ESM1-Akt-MDM2-p53通路调控卵巢癌DNA损伤和抗肿瘤免疫应答的分子机制研究
  • 批准号:
    2026JJ81975
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    肖娇
  • 依托单位:
淫羊藿苷通过TET2介导DNA去甲基化调控Hippo-YAP/TAZ通路逆转绝经后骨质疏松症成血管-成骨耦联失衡的机制研究